Suppr超能文献

反复使用去势促性腺激素释放激素类似物(醋酸亮丙瑞林)治疗母犬的繁殖控制的长期效果。

Long-term effect of repeated deslorelin acetate treatment in bitches for reproduction control.

机构信息

Clinic of Reproductive Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland.

Institute of Veterinary Anatomy, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057, Zurich, Switzerland.

出版信息

Theriogenology. 2021 Oct 1;173:73-82. doi: 10.1016/j.theriogenology.2021.07.015. Epub 2021 Jul 26.

Abstract

Long-acting gonadotropin-releasing hormone (GnRH) analogs, which are approved for male dogs and ferrets, have been used off-label to suppress estrus in bitches predisposed to the side effects of spaying. Health data from the past 12 years were evaluated from bitches without progestogen pretreatment that received deslorelin acetate (DA) to suppress estrus for the first time before the age of 4.5 years. The study population included 32 client-owned bitches repeatedly treated with either 4.7 mg or 9.4 mg DA implants for a period of 5.3 ± 3.4 years (range 0.5-11.3 years). Follow-up information concerning immediate side effects of DA occurring within five months after the first DA treatment (n = 23) as well as long-term side effects of sustained gonadal suppression occurring after five months up to three years (n = 2), three years up to five years (n = 2) or more than five years (n = 8) were assessed through a questionnaire. Treatment was considered successful if no major side effects requiring medical treatment occurred, which applied to 26 out of 32 (81 %) bitches. In the six remaining bitches, the following major side effects led to treatment discontinuation: persistent urinary incontinence (n = 1), reoccurring induced heat (n = 1), uterine disease (n = 3) and/or ovarian tumor (n = 3). The bitches recovered completely after surgical spaying and/or DA implant removal. Minor side effects that did not require therapy or affect animal welfare included body weight changes (n = 18), subtle behavioral changes (n = 13), induced heat (n = 12), coat changes (n = 11), pseudocyesis (n = 6), transient urinary incontinence (n = 4), and/or temporary thickening of the uterine wall with little anechogenic content (n = 2). To examine a possible causal relationship between adverse side effects and DA treatment, further studies should compare the frequency of pathologies between groups of GnRH-treated, intact and spayed bitches of similar breeds and ages. Nevertheless, DA application before the age of 4.5 years may be a means of postponing surgical spaying for several years in breeds at high risk for developing urinary incontinence. Before DA is used in bitches, owners should be fully informed regarding possible side effects.

摘要

长效促性腺激素释放激素(GnRH)类似物已被批准用于雄性犬和雪貂,被用于治疗有绝育副作用风险的发情母犬。本研究评估了过去 12 年来,32 只未接受孕激素预处理的母犬在 4.5 岁之前首次使用醋酸地洛瑞林(DA)抑制发情的数据。研究人群包括 32 只接受过 4.7mg 或 9.4mg DA 植入物治疗的客户拥有的母犬,治疗期为 5.3±3.4 年(0.5-11.3 年)。通过问卷评估了首次 DA 治疗后 5 个月内(n=23)发生的 DA 即刻副作用的随访信息,以及 5 个月至 3 年(n=2)、3 年至 5 年(n=2)或 5 年以上(n=8)持续性腺抑制的长期副作用。如果没有需要治疗的主要副作用,则认为治疗成功,32 只母犬中有 26 只(81%)符合要求。在其余 6 只母犬中,由于以下主要副作用导致治疗停止:持续性尿失禁(n=1)、复发性诱导发情(n=1)、子宫疾病(n=3)和/或卵巢肿瘤(n=3)。这些母犬在接受绝育手术和/或 DA 植入物取出后完全康复。不需要治疗或不影响动物福利的轻微副作用包括体重变化(n=18)、微妙的行为变化(n=13)、诱导发情(n=12)、毛色变化(n=11)、假孕(n=6)、短暂性尿失禁(n=4)和/或子宫壁暂时增厚且回声少(n=2)。为了检查不良反应与 DA 治疗之间的可能因果关系,应进一步比较 GnRH 治疗组、完整组和绝育组的相似品种和年龄母犬之间的病变频率。然而,在 4.5 岁之前使用 DA 可能是一种在有尿失禁风险的品种中推迟绝育手术数年的方法。在 DA 用于母犬之前,应充分告知其主人可能出现的副作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验